1. Home
  2. ORIC vs NMCO Comparison

ORIC vs NMCO Comparison

Compare ORIC & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • NMCO
  • Stock Information
  • Founded
  • ORIC 2014
  • NMCO 2019
  • Country
  • ORIC United States
  • NMCO United States
  • Employees
  • ORIC N/A
  • NMCO N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • NMCO Finance/Investors Services
  • Sector
  • ORIC Health Care
  • NMCO Finance
  • Exchange
  • ORIC Nasdaq
  • NMCO Nasdaq
  • Market Cap
  • ORIC 362.9M
  • NMCO 577.1M
  • IPO Year
  • ORIC 2020
  • NMCO N/A
  • Fundamental
  • Price
  • ORIC $10.71
  • NMCO $10.65
  • Analyst Decision
  • ORIC Strong Buy
  • NMCO
  • Analyst Count
  • ORIC 9
  • NMCO 0
  • Target Price
  • ORIC $18.29
  • NMCO N/A
  • AVG Volume (30 Days)
  • ORIC 987.5K
  • NMCO 207.6K
  • Earning Date
  • ORIC 08-11-2025
  • NMCO 01-01-0001
  • Dividend Yield
  • ORIC N/A
  • NMCO 5.43%
  • EPS Growth
  • ORIC N/A
  • NMCO N/A
  • EPS
  • ORIC N/A
  • NMCO N/A
  • Revenue
  • ORIC N/A
  • NMCO N/A
  • Revenue This Year
  • ORIC N/A
  • NMCO N/A
  • Revenue Next Year
  • ORIC N/A
  • NMCO N/A
  • P/E Ratio
  • ORIC N/A
  • NMCO N/A
  • Revenue Growth
  • ORIC N/A
  • NMCO N/A
  • 52 Week Low
  • ORIC $3.90
  • NMCO $8.52
  • 52 Week High
  • ORIC $14.67
  • NMCO $11.64
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 67.12
  • NMCO 53.91
  • Support Level
  • ORIC $10.42
  • NMCO $10.60
  • Resistance Level
  • ORIC $11.14
  • NMCO $10.88
  • Average True Range (ATR)
  • ORIC 0.59
  • NMCO 0.12
  • MACD
  • ORIC -0.08
  • NMCO 0.00
  • Stochastic Oscillator
  • ORIC 79.49
  • NMCO 50.79

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About NMCO Nuveen Municipal Credit Opportunities Fund

Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.

Share on Social Networks: